NeuroScientific Biopharmaceuticals taking a different approach to treat Alzheimer’s Disease

October, 2019

NeuroScientific Biopharmaceuticals taking a different approach to treat Alzheimer's Disease

Further reading

September, 2022

Investor Update from NSB Chairman Paul Rennie

September, 2022

NeuroScientific Biopharmaceuticals Investor Update Webinar

December, 2021

NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”

November, 2021

Broker Briefing Webinar with Dr Alexandra Andrews